Navigation Links
Ingenuity Systems Joins Biomarkers Consortium
Date:9/18/2007

REDWOOD CITY, Calif., Sept. 18 /PRNewswire/ -- Ingenuity Systems, the leading provider of solutions to explore, analyze, and interpret scientific literature and data, is pleased to announce its membership in the Biomarkers Consortium, a major public-private biomedical research partnership created to discover, develop, and qualify new biological markers to support new drug development, preventive medicine, and medical diagnostics.

The founding members of the Consortium include the Foundation for the National Institutes of Health (FNIH), National Institutes of Health (NIH), Food and Drug Administration (FDA), Centers for Medicare & Medicaid Services (CMS); and the Pharmaceutical Research and Manufacturers of America (PhRMA).

"We are pleased to join the Biomarkers Consortium and to have the opportunity to participate in an evolving dialog with key thought leaders from top research organizations and agencies world-wide," stated Art Okamoto, Senior Product Manager at Ingenuity. "We are excited about the prospects offered by the Biomarkers Consortium, and hope to contribute to the development and accessibility of biomarker research in the scientific community."

Ingenuity is committed to helping life science researchers generate maximum value from all types of biological and chemical knowledge. Ingenuity has recently launched IPA-Biomarker(TM) to help researchers identify and prioritize biomarker candidates based on key biological characteristics. Ingenuity's technology supports the Consortium's goal of advancing biomarker research by linking potential markers to a disease or biological process of interest.

About Ingenuity Systems(R)

Ingenuity Systems enables researchers to model, analyze, and understand complex biological and chemical systems foundational to human health and disease. All of Ingenuity's products and services have one common goal -- to provide relevant context and understanding to life science researchers. The Ingenuity
'/>"/>

SOURCE Ingenuity Systems
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Assess the In Vivo Activation of Signal Transduction Pathways with PathDetect Reporting Systems
2. prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification
3. Performance Comparisons of Commercial RT-PCR Systems
4. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
5. In Vivo Signal Transduction Pathway Reporting Systems
6. Improved Vectors for PathDetect Trans-Reporting Systems
7. Genetic Reporter Systems
8. Genetic Reporter Systems
9. Matched siRNAs and Assays: Ambion + Applied Biosystems = RNAi Success
10. Separation Reproducibility With the BioLogic Chromatography Systems
11. Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Ambassador to also Visit Detroit , ...David Appia, French Ambassador for International I...rance Agency, , , , ,What: Ambassador Appia is av...usiness initiatives adopted by France to further d...e for innovation and development., , ,When: Availa...
(Date:11/24/2009)...RNewswire-FirstCall/--Sigma-AldrichCorporation(Nas...eonTuesday,December1stat1:45PMGMTinLondon,7:45AMUS...stovertheInternetavailableat http://inve s tor....st"icontoaccessthisfile. ,, AboutSigma-Aldric...ologycompany.Itschemicalandbiochemicalproductsandk...
(Date:11/24/2009)...RNewswire-Asia/--ShanghaiBiolaxyannouncedthe,Chine...dthe,investigationalnewdrugapplication(IND)foritso...ulationtotreatdiabetes.ThisIND,approvalallowsBiola...abetesisadisordercharacteristicofhighbloodglucosea...esultinseveremicro-and,macro-vasculardiseases,loss...
(Date:11/24/2009).../PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: ...,today,announcedthatithassubmittedaMAAtotheEuropea...enzymereplacementtherapyindevelopment,forthetreatm...pplicationforvelaglucerasealfathathasbeensubmitted...a. , Basedonaglobalsupplyshortageofthecurrent...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...C., April 2 Chimerix, Inc., a biotechnology compa...ics, announced today that the Company has joined t...work of public-private partnerships to discover, d...ve and affordable antimalarial drugs. The MMV will...ivity against malaria, and any lead candidates tha...
...lution A/S today announced that Merck & Co. In...e collaboration agreement announced in June 2008 t...g discovery technology to identify novel small mol...entering the second phase, Merck gains access to a...mall molecule drug candidates. In addition, this ...
... /PRNewswire-Asia-FirstCall/ -- China Biologic,Pro...logic" or the "Company"),one of the leading plasma...public of China ("PRC"), reported financial result...8 Highlights, -- Revenues increased 44.3% year-...rofit increased 45.7% to $32.7 million over 2007, ...
Other Biology Technology:Chimerix Joins International Network of Organizations to Cure Malaria 2Chimerix Joins International Network of Organizations to Cure Malaria 3Nuevolution Announces Progress in Its Collaboration With Merck & Co. Inc. 2China Biologic Products Announces Strong 2008 Results 2China Biologic Products Announces Strong 2008 Results 3China Biologic Products Announces Strong 2008 Results 4China Biologic Products Announces Strong 2008 Results 5China Biologic Products Announces Strong 2008 Results 6China Biologic Products Announces Strong 2008 Results 7China Biologic Products Announces Strong 2008 Results 8China Biologic Products Announces Strong 2008 Results 9China Biologic Products Announces Strong 2008 Results 10China Biologic Products Announces Strong 2008 Results 11China Biologic Products Announces Strong 2008 Results 12China Biologic Products Announces Strong 2008 Results 13China Biologic Products Announces Strong 2008 Results 14China Biologic Products Announces Strong 2008 Results 15
(Date:11/24/2009)...ambridge, Md. (November 24, 2009) New research on... river ecosystems reveals predictable temporal pat...communities as markers for monitoring climate chan... week in the Proceedings of the National Academy ...ommunities in the six rivers shifted synchronously...
(Date:11/23/2009)... TORONTO, November 23, 2009 - The time of day matt...g to a new paper produced by a research team led b...o Scarborough,s vice-principal for research and co...logy at the St. George campus. , Capitalizing ... poplar tree, the research team examined how popla...
(Date:11/23/2009)... AMES, Iowa - The only swine vaccine available for... herd infected with the virus. The vaccination mar... herd diagnosed with the pandemic flu., Iowa Sta...cience, developed the vaccine this summer and has ...in Iowa, Kansas and Illinois for several weeks., ...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Time of day matters to thirsty trees, U of T researcher discovers 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Glucose metabolism and recidivism of severe violent crimes in alcohol intoxications 47468 1Glucose metabolism and recidivism of severe violent crimes in alcohol intoxications 47468 2New study finds lowfat chocolate milk is effective post exercise recovery aid for soccer players 8670 1New study finds lowfat chocolate milk is effective post exercise recovery aid for soccer players 8670 2Survey Reveals Injectable Procedures Are Mainstream And Accepted Medical Aesthetic Treatment Options 47464 1Survey Reveals Injectable Procedures Are Mainstream And Accepted Medical Aesthetic Treatment Options 47464 2Survey Reveals Injectable Procedures Are Mainstream And Accepted Medical Aesthetic Treatment Options 47464 3Survey Reveals Injectable Procedures Are Mainstream And Accepted Medical Aesthetic Treatment Options 47464 4
...at the University of Massachusetts Medical School ...es the ability of scientists to target individual ...tial implications for both basic science research ...ne led by Scot A. Wolfe, PhD, an assistant profess...d the Department of Biochemistry & Molecular Pharm...
...ity Medical Centre (LUMC) are the first to determi...rst European whose DNA sequence has been determine... morning, during a special press conference at Bes...ss in the Netherlands. , Following in-depth ana...cidental privacy-sensitive findings. The results w...
...e discovered a new strategy for an immunization ag...d that immune cells react strongly to the modified...ect has occurred. It is estimated that this repair...rs. , The researchers, led by Professor Dr. Mag...Department of Applied Tumor Biology at the Heidelb...
Other Biology News:New technique allows targeted inactivation of genes in research model 2Leiden scientists sequence first female DNA 2To fight the cancer before the tumor grows 2
ImageQuant 400 from GE Healthcare, formerly Amersham Biosciences
IMAGEQUANT 100 WKSTN from GE Healthcare, formerly Amersham Biosciences
Cathepsin L Fluorometric (cresyl violet) Assay Kit, Magic Red from AbD Serotec
ImageQuant 300 from GE Healthcare, formerly Amersham Biosciences
Biology Products: